Wnt signalling and prostate cancer
- 5 April 2005
- journal article
- review article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 8 (2) , 119-126
- https://doi.org/10.1038/sj.pcan.4500794
Abstract
The Wnt signalling pathway plays a role in the direction of embryological development and maintenance of stem cell populations. Heritable alterations in genes encoding molecules of the Wnt pathway, including mutation and epigenetic events, have been demonstrated in a variety of cancers. It has been proposed that disruption of this pathway is a significant step in the development of many tumours. Interactions between β-catenin—the effector molecule of the Wnt pathway—and the androgen receptor highlight the pathway's relevance to urological malignancy. Mutation or altered expression of Wnt genes in tumours may give prognostic information and treatments are being developed which target this pathway.Keywords
This publication has 92 references indexed in Scilit:
- Expression of Concern: Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinomaPublished by Wiley ,2004
- Cyclin-dependent kinase 2 regulates the interaction of Axin with β-cateninBiochemical and Biophysical Research Communications, 2004
- Crossregulation of NF‐κB by the APC/GSK‐3β/β‐catenin pathwayMolecular Carcinogenesis, 2004
- The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt PathwayPLoS Biology, 2003
- Synergistic Induction of Tumor Antigens by Wnt-1 Signaling and Retinoic Acid Revealed by Gene Expression ProfilingJournal of Biological Chemistry, 2002
- APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancersGenes, Chromosomes and Cancer, 2002
- Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activationOncogene, 2001
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cellsEuropean Journal Of Cancer, 2000
- GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with AxinOncogene, 2000
- APC mutations occur early during colorectal tumorigenesisNature, 1992